Brevard Achievement Center (BAC)recently a series of personnel moves that the organization says reflects its continued growth ...
Chinese NMPA approves Bayer’s oral ARi Nubeqa in combo with ADT for use in patients with metastatic hormone-sensitive prostate cancer: Berlin Wednesday, February 4, 2026, 14:00 ...
Medicus Pharma Ltd. (Nasdaq: MDCX) is a precision-guided biotech/life sciences company focused on accelerating the clinical development programs of novel and potentially disruptive therapeutics assets ...
The phase 2b study is an open-label trial that will enroll 40 men with advanced prostate cancer who are appropriate candidates for ADT. Participants will receive an initial loading dose of teverelix ...
ADT returns as the presenting partner of FanFest, which will take place at loanDepot park on Saturday, February 7, from 4-8 p ...
Suddenly shutting off external signals and focusing inward can demand a startling amount of energy.
Tolmar, Inc. today announced the launch of Care Partner Corner ( a comprehensive digital resource created specifically to support and empower care partners of prostate cancer patients. This free, easy ...
Major stock indexes closed sharply lower and bitcoin plunged to near $62,000 Thursday amid broad risk-off sentiment, as ...
The Sector Specialised Operations Patrollers (SSOP) held their first community engagement for 2026, which was well-attended ...
Cardio-oncology clinics manage diverse therapy-associated phenotypes including early-onset heart failure, ...
Large drugmakers once had more room to absorb failure, both financially and reputationally | Large drugmakers are facing tighter constraints than in the past, as financial, scientific and reputational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results